Open | - |
Close | - |
Volume / Avg. | 0 / 412.265K |
Day Range | - - - |
52 Wk Range | 1.330 - 4.490 |
Market Cap | $77.067M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 0.71% |
Days to Cover | 3.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Cara Therapeutics (NASDAQ:CARA) and Anebulo Pharmaceuticals (NASDAQ:ANEB).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by Piper Sandler on Tuesday, March 5, 2024. The analyst firm set a price target for 5.00 expecting MIST to rise to within 12 months (a possible 244.83% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $1.45 last updated March 18, 2024 at 5:27 PM EDT.
There are no upcoming dividends for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.